Your browser doesn't support javascript.
loading
Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway.
Ren, Xiaolei; Long, Meijun; Li, Zhihong; Wu, Boda; Jin, Tao; Tu, Chao; Qi, Lin; Yang, Mei.
Afiliación
  • Ren X; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Long M; Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Li Z; Breast Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Wu B; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Jin T; Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Tu C; Department of Medical Genetics, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Qi L; Department of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Yang M; Department of Medical Genetics, The Second Xiangya Hospital, Central South University, Changsha, China.
Cell Death Dis ; 11(6): 464, 2020 06 15.
Article en En | MEDLINE | ID: mdl-32541902

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteínas Cromosómicas no Histona / Fosfatidilinositol 3-Quinasas / Quinasa de Punto de Control 2 Límite: Female / Humans Idioma: En Revista: Cell Death Dis Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteínas Cromosómicas no Histona / Fosfatidilinositol 3-Quinasas / Quinasa de Punto de Control 2 Límite: Female / Humans Idioma: En Revista: Cell Death Dis Año: 2020 Tipo del documento: Article País de afiliación: China